Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DRSplus

K-Number: K192113 · 2019-11-15

Decision Date2019-11-15
Product CodeMYC
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

DRSplus is a medical device manufactured by Centervue S.P.A.. It received FDA 510(k) clearance on 2019-11-15 under approval number K192113. The device is classified under product code MYC. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DRSplus?

DRSplus is a medical device that received FDA 510(k) clearance on 2019-11-15. It is manufactured by Centervue S.P.A.. The 510(k) number is K192113.

When was DRSplus approved by the FDA?

DRSplus received FDA 510(k) clearance on 2019-11-15, under approval number K192113.

What company makes DRSplus?

DRSplus is manufactured by Centervue S.P.A..

What is the FDA product code for DRSplus?

The FDA product code for DRSplus is MYC.

Other Devices by Centervue S.P.A.

View all 8 devices →

Related Devices (Code: MYC)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.